APC/Cyanine7 anti-mouse Ly-6G Antibody

Product Details

Reactivity

Mouse

Antibody Type

Monoclonal

Host Species

Rat

Immunogen

Ly-6G transfected EL-4J cell line.

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.

Preparation

The antibody was purified by affinity chromatography and conjugated with APC/Cyanine7 under optimal conditions.

Concentration

0.2 mg/ml

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser

Red Laser (633 nm)

Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C¹⁵. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A8¹⁵. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.4¹⁶.

Additional reported applications (for the relevant formats) include: immunohistochemistry⁹ of frozen sections¹⁰ and paraffin-embedded sections¹¹, depletion^{4, 12-14}, and spatial biology (IBEX)^20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Additional Product Notes

BioLegend is in the process of converting the name APC/Cy7 to APC/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our APC/Cyanine7 products. Please contact Technical Service if you have any questions.

Application References

(PubMed link indicates BioLegend citation)

1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed

Product Citations

1. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
2. Medler TR et al. 2018. Cancer cell. 34(4):561-578 . PubMed
3. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
4. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
5. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
6. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
7. Minutti CM, et al. 2019. Immunity. 50:645. PubMed
8. Hastings AK, et al. 2019. iScience. 13:339. PubMed
9. Han Y et al. 2019. Cell reports. 27(3):835-846 . PubMed
10. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
11. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
12. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
13. Ho YH, et al. 2019. Cell Stem Cell. 25:407. PubMed
14. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
15. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
16. Matthew B Buechler et al. 2019. Immunity. 51(1):119-130 . PubMed
17. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
18. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
19. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
20. Jaitin DA et al. 2016. Cell. 167(7):1883-1896 . PubMed
21. Murphy M, et al. 2017. Eur J Immunol. 47:880. PubMed
22. Dodd RD, et al. 2017. Cancer Res. 77:4486. PubMed
23. Anderson MC, et al. 2018. Cell Chem Biol. 25:483. PubMed
24. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
25. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
26. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
27. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
28. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
29. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
30. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
31. Kovács B, et al. 2020. Front Immunol. 2.508333333. PubMed
32. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
33. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
34. Currier MA, et al. 2017. Oncotarget. 8:17412. PubMed
35. Lee MC, et al. 2017. J Immunol. 198:3565. PubMed
36. Buzzelli JN, et al. 2019. Am J Physiol Gastrointest Liver Physiol. 316:G251. PubMed
37. Quatrini L, et al. 2018. Nat Immunol. 19:954. PubMed
38. Saleh R, et al. 2018. J Immunol. 201:2042. PubMed
39. Briukhovetska D, et al. 2020. Frontiers in Immunology. 1.428472222. PubMed
40. Cai W, et al. 2019. J Neuroinflammation. 0.788194444. PubMed
41. Kalafati L, et al. 2020. Cell. 183:771. PubMed
42. Price P, et al. 2014. J Virol. 88:10840. PubMed
43. Hyatt L, et al. 2014. PLoS One. 9:109072. PubMed
44. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
45. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
46. Fontana MF, et al. 2015. Parasite Immunol. 37: 470-478. PubMed
47. Hilliard K, et al. 2015. Infect Immun . 83: 4015 - 4027. PubMed
48. Zhang J, et al. 2015. Sci Rep. 5: 15553. PubMed
49. Tan X, et al. 2015. Sci Rep. 5: 15702. PubMed
50. Däbritz J, et al. 2016. Sci Rep. 6:20584. PubMed
51. Woods T, et al. 2016. J Virol. 90: 2783 - 2793. PubMed
52. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
53. Saha S, et al. 2016. Nat Commun. 7:13096. PubMed
54. Sen D, et al. 2016. PLoS One. 11:e0165064. PubMed
55. Wilson R, et al. 2016. Nat Commun. 7:13597. PubMed
56. Tuttle KD, et al. 2020. Cell Rep. 33:108407. PubMed
57. Forte D, et al. 2020. Cell Metab. 32:829. PubMed
58. Kim EH, et al. 2020. Elife. 9:00. PubMed
59. Woods PS, et al. 2020. Am J Respir Cell Mol Biol. 62:243. PubMed
60. Wang YT, et al. 2020. Nat Microbiol. 0.397222222. PubMed
61. Kovacs SB, et al. 2021. STAR Protoc. 2:100244. PubMed
62. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
63. Neupane AS, et al. 2020. Cell. 183(1):110-125.e11. PubMed
64. Guendel F, et al. 2020. Immunity. 53(5):1015-1032.e8. PubMed
65. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
66. Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
67. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
68. Stutz MD, et al. 2021. Immunity. 54(8):1758-1771.e7. PubMed
69. Keerthivasan S, et al. 2021. Immunity. 54(7):1511-1526.e8. PubMed
70. Zaman R, et al. 2021. Immunity. :. PubMed
71. Zhang L, et al. 2020. Cell. 442:181. PubMed
72. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
73. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
74. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
75. Filtjens J, et al. 2021. Nat Commun. 12:2936. PubMed
76. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
77. Frank AC, et al. 2021. Theranostics. 11:7570. PubMed
78. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
79. Wang SK, et al. 2021. JCI Insight. 6: . PubMed
80. Deng J, et al. 2021. JCI Insight. 6:146133. PubMed
81. Yang C, et al. 2020. J Control Release. 326:324. PubMed
82. Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed
83. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
84. Ni Y, et al. 2021. Theranostics. 11:9431. PubMed
85. Franklin DA, et al. 2020. JCI Insight. 5:. PubMed
86. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
87. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
88. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
89. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
90. Linnerbauer M, et al. 2022. Front Immunol. 12:800128. PubMed
91. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
92. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
93. Bresque M, et al. 2022. J Biol Chem. :101711. PubMed
94. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
95. Hulsebus HJ, et al. 2022. Front Immunol. 13:884719. PubMed
96. Grigoryan L, et al. 2022. NPJ Vaccines. 7:55. PubMed
97. Andriessen EMMA, et al. 2021. EMBO Mol Med. 13:e11754. PubMed
98. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
99. Regev O, et al. 2022. Front Immunol. 13:849701. PubMed
100. Rodriguez-Tirado C, et al. 2022. Cancers (Basel). 14:. PubMed
101. Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed
102. Huard A, et al. 2021. J Immunol. 206:1058. PubMed
103. Zou J, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:983. PubMed
104. Saber M, et al. 2021. J Neurotrauma. 38:2862. PubMed
105. Sadhu S, et al. 2021. J Immunol. 207:1812. PubMed
106. Weigert A, et al. 2022. Nat Commun. 13:6078. PubMed
107. Yoshida K, et al. 2022. Sci Rep. 12:17276. PubMed
108. Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed
109. Kfoury YS, et al. 2021. Cell Stem Cell. 28:2090. PubMed
110. Tan YY, et al. 2022. Bio Protoc. 12:e4307. PubMed
111. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
112. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
113. McCauley KE, et al. 2022. Cell Rep Med. 3:100713. PubMed
114. Foo CX, et al. 2023. Eur Respir J. 61: . PubMed
115. Klapproth E, et al. 2022. Nat Commun. 13:7648. PubMed
116. Chen O, et al. 2023. J Clin Invest. 133: . PubMed
117. Li J, et al. 2023. Nat Commun. 14:159. PubMed
118. Xu R 2023. Cell Reports. 42(2):112054. PubMed
119. Tunali G, et al. 2023. J Clin Invest. :. PubMed
120. Sohn J, et al. 2022. Blood Adv. 6:2557. PubMed
121. Wiedemann SJ, et al. 2022. Cell Metab. 34:991. PubMed
122. Zheng Y, et al. 2022. Proc Natl Acad Sci U S A. 119:e2121077119. PubMed
123. Pérez-Torrado V, et al. 2022. Bio Protoc. 12:. PubMed
124. Ivan DC, et al. 2023. Acta Neuropathol Commun. 11:35. PubMed
125. Chung KJ, et al. 2023. Int J Mol Sci. 24:. PubMed
126. Houlder E, et al. 2023. Nat Commun. 14:1863. PubMed
127. Hernandez VG, et al. 2023. Glia. 71:1960. PubMed
128. Scieszka DP, et al. 2023. Respir Res. 24:138. PubMed
129. Yashchenko A, et al. 2023. Front Immunol. 14:1082078. PubMed

RRID

AB_10645331 (BioLegend Cat. No. 127623)
AB_10640819 (BioLegend Cat. No. 127624)

Antigen Details

Structure

A 21-35 kD GPI-anchorded membrane protein

Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type

Granulocytes, Macrophages, Monocytes

Biology Area

Immunology, Innate Immunity

Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID

546644 View all products for this Gene ID

UniProt

View information about Ly-6G on UniProt.org

Documentation

• Technical Data Sheet (pdf)
• Certificate of Analysis
• Safety Data Sheet

Reviews

Related Protocols

• Cell Surface Flow Cytometry Staining Protocol

Related Pages & Pathways

Related FAQs

Other Formats

Concentration & Expiration Lookup

Certificate of Analysis